Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Noninfectious inflammatory response to gold weight eyelid implants. Ophthalmic Plast Reconstr Surg 1995 Sep;11(3):209-14

Date

09/01/1995

Pubmed ID

8541263

DOI

10.1097/00002341-199509000-00008

Scopus ID

2-s2.0-0029084586 (requires institutional sign-in at Scopus site)   54 Citations

Abstract

We describe three patients with noninfectious inflammatory reactions to gold weight eyelid implants, a complication not previously reported. Eyelid edema and erythema developed gradually in each patient, and maximal inflammation that prompted treatment was present at 12, 3, and 5 weeks, respectively, after surgery in the three patients. Management involved removal of the implant in the first patient, oral corticosteroids followed by replacement of the implant by a platinum weight in the second patient, and a local corticosteroid injection with retention of the implant in the third. Histopathological features included a thick eosinophilic coagulum at the tissue-gold interface and an intense, predominantly lymphocytic infiltrate in the collagenous capsule that surrounded the implants. Gold weight eyelid implants can elicit a gradually progressive inflammatory response. In at least some cases, local corticosteroid injection may suppress the inflammation and permit retention of the implant.

Author List

Bair RL, Harris GJ, Lyon DB, Komorowski RA

Author

Gerald J. Harris MD Professor in the Ophthalmology and Visual Sciences department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Aged
Aged, 80 and over
Anti-Inflammatory Agents
Blepharitis
Edema
Erythema
Eyelid Diseases
Eyelids
Facial Paralysis
Female
Gold
Humans
Keratitis
Middle Aged
Prostheses and Implants
Reoperation
Steroids